Having confirmed castration levels of testosterone in the APSCE to be comparable with the conventional model of ADT in steroid-depleted medium (SDM) [30, 31] (Fig. 4b), we noted a paradoxical upregulation of AR target gene expression following culture of castration-resistant prostate cancer cells CWR22Rv1 in APSCE (Fig. 4c, Fig. S5B). The gene discussed is AR; the disease is prostate carcinoma.